期刊文献+

建立痛风性肾病并发慢性肾功能衰竭动物模型方法的探讨 被引量:22

Exploration on the Establishment of Animal Models for Gouty Nephropathy Complicated with Chronic Renal Failure
暂未订购
导出
摘要 目的探讨痛风性肾病并发慢性肾功能衰竭(简称慢肾衰)动物模型的建立方法。方法以10%高酵母饲料喂养6~8周龄雄性Wistar大鼠,分别以100、150、200、250、300mg/(kg.d)腺嘌呤灌胃,动态监测大鼠血清尿素氮(BUN)、肌酐(Cr)及血尿酸(UA)水平的变化,同时观察大鼠肾脏病理改变。结果与正常对照组比较,以100mg/(kg.d)腺嘌呤灌胃7天,大鼠血清BUN、Cr及血UA均明显升高(P<0.05),同时肾脏病理组织学出现痛风性肾病的病理改变,随着造模时间的延长,上述生化指标及肾脏病理组织学变化更明显,在第26天(约4周)血Cr达到慢肾衰水平,而41天(约第6周)血Cr明显超过慢肾衰水平。血UA于造模后第7天达到较高水平,较长时间内维持在高水平上,血UA在第41~48天之间迅速下降,肾脏病理组织学淋巴细胞浸润,纤维组织增生加重,造模48天时在上述病变基础上纤维组织增生明显,间质纤维化。而其他剂量腺嘌呤灌胃至14天,与正常对照组比较,血清BUN、Cr及血UA均明显升高(P<0.05),达到肾功能衰竭水平;恢复正常饲料喂养,17天后血清BUN、Cr及血UA水平明显下降,至35天时,上述指标恢复接近正常水平。结论用10%高酵母饲料喂养雄性Wistar大鼠,同时予以100mg/(kg.d)体重腺嘌呤灌胃5周,可建立理想的痛风性肾病并发慢肾衰的实验动物模型。 Objective To explore the method for establishing animal models of gouty nephropathy complicated with chronic renal failure.Methods Six-eight weeks old male Wistar rats were fed with 10% fodder yeast.The adenine at the daily dose of 100,150,200,250,and 300 mg/kg was administrated to them by gastrogavage.The serum levels of blood urea nitrogen(BUN),creatinine(Cr),and uric acid(UA) were dynamically monitored.Meanwhile,the pathological changes of rat kidney were observed.Results Compared with the normal control group,serum BUN,Cr,and UA obviously increased in rats administered with 100 mg/kg for 7 days(P0.05).Meanwhile,pathological changes as gouty nephropathy occurred.Along with the prolongation of the modeling time,the aforesaid biochemical indices and pathohistological changes of the kidney were more obvious.The blood Cr level just reached the chronic renal failure level on the 26th day of the administration(about the 4th week),and obviously exceeded the renal failure level on the 41st day(about the 6th week).The blood UA level increased to a higher level on the 7th day of modeling,and maintained at a higher level for a long time.It decreased rapidly from the 41st day to the 48th day.The renal pathological examination showed aggravated infiltration of lymphocytes and stromal fibrous proliferation.On the 48th day of modeling,the proliferation of the fibrious tissue and the interstitial fibrosis were obvious on the bases of the aforesaid changes.The serum BUN,Cr,and blood UA obviously increased in the rats administered with 150,200,250,and 300 mg/kg when compared with the normal control group,reaching the level of chronic renal failure(P0.05).These levels obviously decreased 17 days after restoring to normal fodder feeding,and approached the normal levels till the 35th day.ConclusionIdeal experimental animal models of gouty nephropathy complicated with chronic renal failure could be established in male Wistar rats by feeding with 10% fodder yeast and 100 mg/kg adenine by gastrogavage for 5 weeks.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2011年第10期1409-1413,共5页 Chinese Journal of Integrated Traditional and Western Medicine
基金 山东省青岛市科技局资助项目(No.07-2-1-19-nsh)
关键词 高尿酸血症 肾病 慢性肾功能衰竭 动物模型 hyperuricemia nephropathy chronic renal failure animal model
  • 相关文献

参考文献9

  • 1高志卿,邓跃毅,王琳,陈以平.慢性尿酸性肾病动物模型研究及中医药对其的影响[J].中国中西医结合杂志,2005,25(2):186-189. 被引量:3
  • 2蒋季杰.尿酸肾病.国外医学:内科学分册,1989,16(1):24-24.
  • 3蒋明 朱立平 林孝义 主编.风湿病学[M].北京:科学出版社,1998.1031-1032.
  • 4王海燕.肾脏病学[M]第2版[M].北京:人民卫生出版社,1998.103-104.
  • 5陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 6Klinenberg JR,Kippen I,Bluestone R.Hyperuricemic nephropathy:pathologic features and factors influencing urate deposition[J].Nephron,1975,14(1):88-98.
  • 7Philips FS,Thiersch JB,Bendich A.Adenine intoxication in relation to in vivo formation and deposition of 2,8-dioxyadenine in renal tubules[J].J Pharmacol Exp Ther,1952,104(1):20-30.
  • 8奚九一,赵兆琳,鲁培基,屈立志,王义成.高尿酸血症肾病的实验动物模型研究[J].上海中医药杂志,2001,35(10):10-12. 被引量:53
  • 9何立群,聂永红,邹士林.新型尿酸性肾病动物模型的建立[J].上海实验动物科学,2001,21(1):22-25. 被引量:32

二级参考文献28

  • 1郑平东,朱燕俐.用腺嘌呤制作慢性肾功能衰竭动物模型[J].中华肾脏病杂志,1989,5(6):342-344. 被引量:115
  • 2张梓荣.腺嘌呤所致大鼠慢性肾功能衰竭的病理形态改变及其应用意义[J].北京实验动物科学与管理,1994,11(3):58-58.
  • 3周小舟,张盛光,阳晓,魏毅.腺嘌呤所致大鼠慢性肾功能衰竭的机理研究[J].基础医学与临床,1997,17(1):54-57. 被引量:77
  • 4Zhang B, Liu XQ, Zhang HJ, et al. Establishment of mouse models of hyperuricaemia complicated with hyerlipidemia and its pathogensis. J New Drug Clin Pharmacol Tradit Chin Med 2002; 13(2) :80-82.12.Hall IH, Scoville JP, Reynolds DJ, et al. Substituted cyclic imides as potential anti-gout agents. Life Sci 1990;46(26):1923-1927.
  • 5Philips FS, Thiersch JB, Bendich A, et al. Adenine intoxication in relation to in vivo formation and deposition of 2, 8-dioxyadenine in renal tubules. J Pharmacal Exp Ther 1952;104(1) :20-30.
  • 6Wu X, Wakamiya M, Vaishnav S, et al. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci USA 1994;91(2):742-746.
  • 7Kelly SJ, Delnomdedieu M, Oliverio MI, et al. Diabetes insipidus in uricase-deficient mice: A model for evaluating therapy with poly (ethylene glycol)-modified uricase. J Am Soc Nephrol 2001;12(5) :1001-1009.
  • 8Waisman J, Bluestone R, Klinenberg JR. A preliminary report of nephropathy in hyperuricemic rats. Lab Invest 1974;30(6) :716-722.
  • 9Bluestone R, Brady S, Waisman J, et al. Experimental hyperuricemic nephropathy. A model for human urate deposition disease. Arthritis Rheum 1975 ;18(6 Suppl) :823-834.
  • 10Bluestone R, Waisman J, Klinenberg JR. Chronic experimental hyperuricemic nephropathy. Lab Invest 1975; 33 (3):273-279.

共引文献1980

同被引文献237

引证文献22

二级引证文献172

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部